Indeed, there have been calls for additional clinical trials of tPA treatment to be conducted [18], leading to re-analysis of the National Institute of Neurological Disorders and Stroke trial data [19], and the spread of uncertainty towards use of this therapy [20]. This evidence concerns the gene PLAT and stroke disorder.